SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-013526
Filing Date
2024-02-14
Accepted
2024-02-13 19:34:50
Documents
16
Period of Report
2024-02-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea193698-8k_inmedpharm.htm   iXBRL 8-K 27260
2 NEWS RELEASE, DATED FEBRUARY 13, 2024 ea193698ex99-1_inmedpharm.htm EX-99.1 97854
6 GRAPHIC ex99-1_001.jpg GRAPHIC 5102
  Complete submission text file 0001213900-24-013526.txt   321149

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE inm-20240213.xsd EX-101.SCH 3021
4 XBRL LABEL FILE inm-20240213_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE inm-20240213_pre.xml EX-101.PRE 22364
18 EXTRACTED XBRL INSTANCE DOCUMENT ea193698-8k_inmedpharm_htm.xml XML 3733
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 24631175
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)